AMRA Medical has received FDA clearance for AMRAÒ Profiler, now available for use in a clinical setting in the US. AMRAÒ Profiler is indicated for use as a magnetic resonance

The company is partnering with Beijing University Cancer Hospital and Konica Minolta in a clinical trial to assess the efficacy of scalp cooling for chemotherapy-induced hair loss in women with

The company has announced new data from the CERTiFy (CERAMENT Treatment of Tibia Plateau Fracture defects) study comparing CERAMENT|BVF with autologous iliac bone graft (autograft). “Successfully completing the ground-breaking CERTiFy study, to demonstrate

OssDsign AB has announced positive results from a retrospective study of OSSDSIGN Cranial PSI that has been accepted for publication in World Neurosurgery. The retrospective study carried out at Karolinska University

The company announces that it has started selling CERAMENT BVF direct via its own US distributor network. “The launch of our own US distribution network is a key strategic milestone

Acarix and MED Management are entering into an agreement for the German outpatient market. “The CADScor system is perfectly suited for supporting MED Management’s overall strategy of offering solutions to